National Institute of Nursing Research; Notice of Closed Meetings, 2879 [2016-00801]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 11 / Tuesday, January 19, 2016 / Notices
asabaliauskas on DSK5VPTVN1PROD with NOTICES
eligible submission (a) complies with
the rules in this Federal Register notice,
(b) follows the detailed submission
instructions at https://pir.nlm.nih.gov/
challenge/, (c) is complete (e.g., meets
the Submission Requirements above),
and (d) is confirmed by NLM that the
executable is an implementation of the
submitted source code, can be run on
the submitted virtual machine using
directories DC and DR as input, and the
output matrix is the same as the
submission’s matrix MRC.
Eligible submissions will proceed to
the judging process, and will be
evaluated based on how well the
submissions can match pill images
across a large number of queries. NLM
has developed evaluation software and
created directories of images to use in
selecting the Challenge winners. For
example, directories DRJ and DCJ (J for
Judging) contain reference and
consumer-quality images similar to
those in directories DR and DC provided
to potential Challenge participants, and
the ground truth matrix for judging
MGTJ has MGTJ(i,j)=1 if DCJ(i) and
DRJ(j) are photos of the same pill, else
MGTJ(i,j)=0. The evaluation software
calculates the mean average precision
(MAP) for directories and ground truth
matrix such as DRJ, DRC, and MGTJ.
Mean average precision is a widely used
measure for evaluating how well
information retrieval systems (for
example, search engines) retrieve results
across a large number of queries. The
MAP formula and examples of MAP
calculations for this Challenge are at
https://pir.nlm.nih.gov/challenge/MAP_
example.
The eligible submissions will be
submitted to the evaluation software.
The submission with the highest MAP
score will be recommended as the first
place winner, with the second, third,
fourth, and fifth best MAPs, respectively
being recommended to earn second
place, third place, and two honorable
mentions. In the event of tied scores, the
tied submissions will be tested against
additional DRJ and DCJ directories until
a winner is determined. Dr. Terry Yoo
will serve as the judge for the
competition, thereby overseeing the
evaluation software process and being
responsible for its proper application.
Additional Information
The NLM Computational Photography
Project for Pill Identification (C3PI) is a
research and development project in the
Office of High Performance Computing
and Communications (OHPCC) within
the NLM Lister Hill National Center for
Biomedical Communications
(LHNCBC). C3PI computer scientists
conduct computer vision R&D in text-
VerDate Sep<11>2014
17:50 Jan 15, 2016
Jkt 238001
and image-based search and retrieval.
C3PI’s overall goal is to help improve
the prescription drug information made
available to health professionals and
consumers. The NLM ‘‘Pill Image
Recognition Request for Information’’
(PIR RFI) (https://www.fbo.gov/
index?s=opportunity&
mode=form&id=a1a694718366ea
7cbaf8f715047d63e1&tab=core&_
cview=0) was a pilot for this Challenge.
The RFI was announced in February
2015 and responses were due in May
2015. RFI responses were used to test,
evaluate, and as needed refine the
components of the Challenge, including
its instructions. NLM appreciates the
work done by the parties that responded
to the RFI.
Dated: January 11, 2016.
Betsy L. Humphreys,
Acting Director, National Library of Medicine,
National Institutes of Health.
[FR Doc. 2016–00777 Filed 1–15–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Nursing Research;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Nursing Research Special Emphasis Panel;
MHealth Tools for Underserved Populations.
Date: February 9, 2016.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, Office of Review, National
Institute of Nursing Research, National
Institutes of Health, 6701 Democracy
Boulevard, Suite 710, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Mario Rinaudo, MD,
Scientific Review Officer, One Democracy
Plaza, Office of Review, National Institute of
Nursing Research, National Institutes of
Health, 6701 Democracy Boulevard, Suite
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
2879
710, Bethesda, MD 20892, 301–594–5973,
mrinaudo@mail.nih.gov.
Name of Committee: National Institute of
Nursing Research Initial Review Group.
Date: February 18, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Weiqun Li, MD, Scientific
Review Officer, National Institute of Nursing
Research, National Institutes of Health, 6701
Democracy Blvd., Ste. 710, Bethesda, MD
20892, (301) 594–5966, wli@mail.nih.gov.
Name of Committee: National Institute of
Nursing Research Special Emphasis Panel;
Palliative and End-of-Life Care Research.
Date: February 24, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Tamizchelvi Thyagarajan,
Ph.D., Scientific Review Officer, National
Institute of Nursing Research, National
Institutes of Health, Bethesda, MD 20892,
301–594–0343, tamizchelvi.thyagarajan@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.361, Nursing Research,
National Institutes of Health, HHS)
Dated: January 11, 2016.
Sylvia Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–00801 Filed 1–15–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; DDK–D Member
Conflict SEP.
Date: February 5, 2016.
E:\FR\FM\19JAN1.SGM
19JAN1
]]>Agencies
[Federal Register Volume 81, Number 11 (Tuesday, January 19, 2016)]
[Notices]
[Page 2879]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-00801]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Nursing Research; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Nursing Research
Special Emphasis Panel; MHealth Tools for Underserved Populations.
Date: February 9, 2016.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, One Democracy Plaza,
Office of Review, National Institute of Nursing Research, National
Institutes of Health, 6701 Democracy Boulevard, Suite 710, Bethesda,
MD 20892, (Telephone Conference Call).
Contact Person: Mario Rinaudo, MD, Scientific Review Officer,
One Democracy Plaza, Office of Review, National Institute of Nursing
Research, National Institutes of Health, 6701 Democracy Boulevard,
Suite 710, Bethesda, MD 20892, 301-594-5973, mrinaudo@mail.nih.gov.
Name of Committee: National Institute of Nursing Research
Initial Review Group.
Date: February 18, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott Suites, 6711 Democracy Boulevard,
Bethesda, MD 20817.
Contact Person: Weiqun Li, MD, Scientific Review Officer,
National Institute of Nursing Research, National Institutes of
Health, 6701 Democracy Blvd., Ste. 710, Bethesda, MD 20892, (301)
594-5966, wli@mail.nih.gov.
Name of Committee: National Institute of Nursing Research
Special Emphasis Panel; Palliative and End-of-Life Care Research.
Date: February 24, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott Suites, 6711 Democracy Boulevard,
Bethesda, MD 20817.
Contact Person: Tamizchelvi Thyagarajan, Ph.D., Scientific
Review Officer, National Institute of Nursing Research, National
Institutes of Health, Bethesda, MD 20892, 301-594-0343,
tamizchelvi.thyagarajan@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.361,
Nursing Research, National Institutes of Health, HHS)
Dated: January 11, 2016.
Sylvia Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-00801 Filed 1-15-16; 8:45 am]
BILLING CODE 4140-01-P
